about
CD34+-selected versus unmanipulated autologous stem cell transplantation in multiple myeloma: impact on dendritic and immune recovery and on complications due to infection.The role of MDR-related proteins in the prognosis of adult acute myeloid leukaemia (AML) with normal karyotype.Fludarabine-based induction therapy does not overcome the negative effect of ABCG2 (BCRP) over-expression in adult acute myeloid leukemia patients.ABCG2, Cytogenetics, and Age Predict Relapse after Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in Complete Remission.High CD200 expression is associated with poor prognosis in cytogenetically normal acute myeloid leukemia, even in FlT3-ITD-/NPM1+ patients.Clinical impact of CD200 expression in patients with acute myeloid leukemia and correlation with other molecular prognostic factors.ABCG2 and CD200 define patients at high risk of relapse in ELN favorable subgroup of AML.Functional regulation of the apurinic/apyrimidinic endonuclease 1 by nucleophosmin: impact on tumor biology.Efficacy and safety of rituximab in type II mixed cryoglobulinemia.Treatment of Ph+ chronic myeloid leukemia by gamma interferon.ABCG2 overexpression in patients with acute myeloid leukemia: Impact on stem cell transplantation outcome.Q141K polymorphism of ABCG2 protein is associated with poor prognosis in adult acute myeloid leukemia treated with idarubicin-based chemotherapy.Nocardiosis with favourable clinical outcome in progressive B-chronic lymphocytic leukaemia.Epstein-Barr virus reactivation in a patient treated with anti-thymocyte globulin for severe aplastic anemia.CD56 antigenic expression in acute myeloid leukemia identifies patients with poor clinical prognosis.Unexpected phenotype of a typical NPM1 mutant.Clinical characteristics, prognostic factors and multidrug-resistance related protein expression in 36 adult patients with acute promyelocytic leukemia.Incidence, outcome, and risk factors of late-onset noninfectious pulmonary complications after unrelated donor stem cell transplantation.Successful treatment of hematological and extramedullary relapse of MLL-positive acute lymphoblastic leukemia after bone marrow transplantation using donor leukocyte infusion.Effect of amifostine on the cytotoxicity of daunorubicin and daunoxome in tumor and normal cells.Caspofungin as first line therapy of pulmonary invasive fungal infections in 32 immunocompromised patients with hematologic malignancies.Analysis of IgV gene mutations in B cell chronic lymphocytic leukaemia according to antigen-driven selection identifies subgroups with different prognosis and usage of the canonical somatic hypermutation machinery.Kinetics of Th1/Th2 cytokines and lymphocyte subsets to predict chronic GVHD after allo-SCT: results of a prospective study.ABCG2 overexpression and deoxyadenosine analogue activity in acute myeloid leukemia.Impact of fludarabine-based induction therapy on outcome of FLT3-/NPM1+ cytogenetically normal acute myeloid leukemia.BAALC overexpression retains its negative prognostic role across all cytogenetic risk groups in acute myeloid leukemia patients.A comparative analysis of the sensitivity of multidrug resistant (MDR) and non-MDR cells to different anthracycline derivatives.Autologous transplantation of granulocyte colony-stimulating factor-primed bone marrow is effective in supporting myeloablative chemotherapy in patients with hematologic malignancies and poor peripheral blood stem cell mobilizationA simple prognostic scoring system for newly diagnosed cytogenetically normal acute myeloid leukemia: retrospective analysis of 530 patientsGranulocyte-macrophage colony-stimulating factor in acute non-lymphocytic leukemia before and after chemotherapySensitivity of Ph 1 + CFU-GM to human recombinant interferon alpha and gamma alone and in combinationP170 glycoprotein expression and impaired anthracycline retention in chronic myeloid leukaemiaThe presence of lymphoid-associated antigens in adult acute myeloid leukemia is devoid of prognostic relevanceEvaluation of the clinical relevance of the anionic glutathione-s-transferase (GST pi) and multidrug resistance (mdr-1) gene coexpression in leukemias and lymphomasVisualization of PGP 9.5 immunoreactive nerve terminals in the mouse snout epidermisPrognostic significance of the detection of tumour cells in peripheral blood stem cell collections in stage II and III breast cancer patients treated with high-dose therapyLamivudine allows completion of chemotherapy in lymphoma patients with hepatitis B reactivationAutologus stem cell transplantation as postremission therapy for acute myeloid leukemia. Risk factors at diagnosis can predict the outcomeP-glycoprotein (PGP), lung resistance-related protein (LRP) and multidrug resistance-associated protein (MRP) expression in acute promyelocytic leukaemiaDendritic cell recovery after autologous stem cell transplantation
P50
Q33186135-6E2CB168-DBE6-4A27-AD36-22B35A128EEBQ33268051-BA3FE831-730D-42A0-8E0F-E3B343EE32CEQ33528324-C8C47FC0-73E7-4ED2-AC8F-CE07E352F26DQ36017746-35E7099C-9669-40F0-BC1D-8A8B4D36DB76Q36346270-8D5A2B41-4D72-4AA1-AA75-AE8F831BDE23Q36557537-48C96B26-6C7C-45FD-AA10-DA4721F97910Q38724266-427994FF-D3F3-488A-9EA2-3AB52518AB56Q39129437-608FD276-EABE-4672-B5A0-C0266A390EECQ40566328-613EFADF-6C98-4D72-A803-F3208D852D16Q40773835-E7E6563D-FD7E-4E71-8A1F-6FD0699A7312Q40852245-8CF16F86-6F57-4B75-85BF-DAB35C1980E0Q43156039-5BA79A17-7E24-423D-B64F-BB934B190E2DQ43523104-722E828E-6FE7-40B4-BA2A-A49BCA3A5C91Q43689191-F68DEC2A-48EE-4EF6-8E23-AD968FAFD463Q43692566-0A265ABA-2156-4354-B9C6-E49A1DBABD41Q44043518-6CAFCE2C-838D-4B9B-86C0-83B2AE2CB4F7Q44474610-F418C341-7434-4620-B80A-C3252F239F85Q44750603-8FF641D4-F02A-44D6-A746-6E6AED4E7E9BQ45010805-8C10A63A-F7CF-43B8-846F-958F1170C8EFQ46587135-B879E493-33EF-4B4B-9802-BE6B2E7128A6Q46653990-915422BE-37B8-4DF5-8447-6A06466449CFQ47339225-A9EE5B6A-A8C4-445B-9FB8-FCACB5E23634Q47928807-0F97F6B3-8E77-48E4-9F9A-536E74DCD173Q48155231-C8700044-DD3B-45F8-8017-7774562F4A4BQ48363222-29C03D77-E828-4B53-8CDD-7D9157A25C9AQ50913559-AF6D1588-0AC2-4B68-B2D5-F2386E70FC1CQ54249265-3FA4A4F6-78BC-4BFE-98A7-BFDD71B9FF8FQ57003135-63C3F9C7-B524-4B52-A325-9F095F79DE4FQ60171356-07586903-6D5F-4122-A53E-F19E3CB078B5Q68069148-4739C90A-7207-409B-9B0D-8383F92B5D25Q70394788-32E01CD7-9400-4266-97E1-6CC442F28415Q70949265-E1BE65D3-9C18-4779-9FE5-236907160BC5Q71720128-4B39D726-FD1A-4BDB-989E-D076216215D1Q72586473-82E60713-308F-4B61-91E0-37EECAE48C92Q72845809-723883D4-EE5E-4363-A40B-E1F7DFDD2DD4Q73356970-15C446F4-E611-4EFB-8DE6-0F383167C28DQ73486071-B860D144-1334-402F-950B-50E6CC6FC915Q73650079-7A6B6C39-AD74-44B3-8732-75E7CBD28B9BQ73738390-06987AB6-773C-40B7-AC21-B88588DF1365Q74713909-8EFFEC77-0516-454D-B1DF-07188B9B9A12
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Daniela Damiani
@ast
Daniela Damiani
@en
Daniela Damiani
@es
Daniela Damiani
@nl
type
label
Daniela Damiani
@ast
Daniela Damiani
@en
Daniela Damiani
@es
Daniela Damiani
@nl
prefLabel
Daniela Damiani
@ast
Daniela Damiani
@en
Daniela Damiani
@es
Daniela Damiani
@nl
P106
P1153
57193119029
P21
P31
P496
0000-0002-1663-4468